1. Kardassis D, Vindis C, Stancu CS  et al. Unravelling molecular mechanisms in atherosclerosis using cellular models and omics technologies. Vascul Pharmacol. 2024 Dec 10:158:107452. doi: 10.1016/j.vph.2024.107452. 

2. Rusu-Nastase EG, Lupan AM, Marinescu CI et al. MiR-29a Increase in Aging May Function as a Compensatory Mechanism Against Cardiac Fibrosis Through SERPINH1 Downregulation. Front Cardiovasc Med. 2022 Jan 18;8:810241. doi: 10.3389/fcvm.2021.810241. 

​3. Liehn EA, Lupan AM, Diaconu R et al. Heart function assessment during aging in apolipoprotein E knock-out mice. Discoveries (Craiova). 2021 Sep 28;9(3):e136. doi: 10.15190/d.2021.15. 

4. Neculachi CA, Neti LI, Burlacu A, Preda MB. Inflammation and Hypoxia Negatively Impact the Survival and Immunosuppressive Properties of Mesenchymal Stromal Cells In Vitro. Rom J Cardiol. 2021; 31 (3): 547. doi:10.47803/rjc.2021.31.3.547.

​5. Marinescu CI, Preda MB, Neculachi CA et al. Identification of a hematopoietic cell population emerging from mouse bone marrow with proliferative potential in vitro and immunomodulatory capacity. Front Immunol. 2021 Aug 3;12:698070. doi: 10.3389/fimmu.2021.698070

​6. Lupan AM*, Rusu EG*, Preda MB et al. miRNAs generated from Meg3-Mirg locus are downregulated during aging. Aging (Albany NY). 2021 Jun 22;13(12):15875-15897. doi: 10.18632/aging.203208.

​7. Marinescu CI, Preda MB, Burlacu A. A procedure for in vitro evaluation of the immunosuppressive effect of mouse mesenchymal stem cells on activated T cell proliferation. Stem Cell Res Ther. 2021 Jun 5;12(1):319. doi: 10.1186/s13287-021-02344-3.

​8. Preda MB, Neculachi CA, Fenyo IM et al. Short lifespan of syngeneic transplanted MSC is a consequence of in vivo apoptosis and immune cell recruitment in mice. Cell Death Dis. 2021 Jun 2;12(6):566. doi: 10.1038/s41419-021-03839-w.

​9. Popescu S, Preda MB, Marinescu CI et al. Dual Stem Cell Therapy Improves the Myocardial Recovery Post-Infarction through Reciprocal Modulation of Cell Functions. Int J Mol Sci. 2021 May 26;22(11):5631. doi:10.3390/ijms22115631.

1. Wu X, Niculite CM, Preda MB et al. Regulation of cellular sterol homeostasis by the oxygen responsive noncoding RNA lincNORS. Nat Commun. 2020 Sep 21;11(1):4755. doi: 10.1038/s41467-020-18411-x.

2. Preda MB, Lupan AM, Neculachi CA et al. Evidence of mesenchymal stromal cell adaptation to local microenvironment following subcutaneous transplantation. J Cell Mol Med. 2020 Sep;24(18):10889-10897. doi: 10.1111/jcmm.15717. 

​3. Hristov I, Mocanu V, Zugun-Eloae F al. Association of intracellular lipid accumulation in subcutaneous adipocyte precursors and plasma adipokines in bariatric surgery candidates. Lipids Health Dis. 2019 Jun 13;18(1):141. doi: 10.1186/s12944-019-1081-9.

​4. Lupan AM, Preda MB, Burlacu A. A standard procedure for lentiviral-mediated labeling of murine mesenchymal stromal cells in vitro. Biotechnol Appl Biochem. 2019 Jul;66(4):643-653. doi: 10.1002/bab.1765.

​5. Yakala GK, Cabrera-Fuentes HA, Crespo-Avilan GE et al. FURIN Inhibition Reduces Vascular Remodeling and Atherosclerotic Lesion Progression in Mice. Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):387-401. doi: 10.1161/ATVBAHA.118.311903.

​6. Rosca AM, Mitroi DN, Cismasiu V et al. Collagen regulates the ability of endothelial progenitor cells to protect hypoxic myocardium through a mechanism involving miR-377/VE-PTP axis. J Cell Mol Med. 2018 Oct;22(10):4700-4708. doi: 10.1111/jcmm.13712. 

​7. Tutuianu R, Popescu LM, Preda MB et al. Evaluation of the Ability of Nanostructured PEI-Coated Iron Oxide Nanoparticles to Incorporate Cisplatin during Synthesis. Nanomaterials (Basel). 2017 Oct 12;7(10):314. doi: 10.3390/nano7100314.

​8. Odent Grigorescu G, Rosca AM, Preda MB et al. Synergic effects of VEGF-A and SDF-1 on the angiogenic properties of endothelial progenitor cells. J Tissue Eng Regen Med. 2017 Nov;11(11):3241-3252. doi: 10.1002/term.2233. 

​9. Gradinaru S, Popescu LM, Piticescu RM et al. Repair of the Orbital Wall Fractures in Rabbit Animal Model Using Nanostructured Hydroxyapatite-Based Implant. Nanomaterials (Basel). 2016 Jan 7;6(1):11. doi: 10.3390/nano6010011.

​10. Odent-Grigorescu G*, Preda MB*, Radu E, et al. Combinatorial approach for improving the outcome of angiogenic therapy in ischemic tissues. Biomaterials. 2015 Aug;60:72-81. doi: 10.1016/j.biomaterials.2015.05.002.

11 Preda MB, Rosca AM, Tutuianu R et al. Pre-stimulation with FGF-2 increases in vitro functional coupling of mesenchymal stem cells with cardiac cells. Biochem Biophys Res Commun. 2015 Aug 21;464(2):667-73. doi: 10.1016/j.bbrc.2015.07.055.

​12. Curaj A, Wu Z, Fokong S, Liehn EA et al. Noninvasive molecular ultrasound monitoring of vessel healing after intravascular surgical procedures in a preclinical setup. Arterioscler Thromb Vasc Biol. 2015 Jun;35(6):1366-73. doi: 10.1161/ATVBAHA.114.304857. 

​13. Preda MB, Rønningen T, Burlacu A et al. Remote transplantation of mesenchymal stem cells protects the heart against ischemia-reperfusion injury. Stem Cells. 2014 Aug;32(8):2123-34. doi: 10.1002/stem.1687.

​14. Projahn D, Simsekyilmaz S, Singh S et al. Controlled intramyocardial release of engineered chemokines by biodegradable hydrogels as a treatment approach of myocardial infarction. J Cell Mol Med. 2014 May;18(5):790-800.  doi: 10.1111/jcmm.12225. 

​15. Burlacu A, Grigorescu G, Rosca AM et al. Factors secreted by mesenchymal stem cells and endothelial progenitor cells have complementary effects on angiogenesis in vitro. Stem Cells Dev. 2013 Feb 15;22(4):643-53. doi: 10.1089/scd.2012.0273. 

​16. Burlacu A. Tracking the mesenchymal stem cell fate after transplantation into the infarcted myocardium. Curr Stem Cell Res Ther. 2013 Jul;8(4):284-91. doi: 10.2174/1574888x113089990047.

​17. Burlacu A. Advances in stem cell therapy for myocardial regeneration. Curr Stem Cell Res Ther. 2013 Jul;8(4):269. doi: 10.2174/1574888x11308040001. 

18. Preda MB, Burlacu A, Simionescu M. Defined-size embryoid bodies formed in the presence of serum replacement increases the efficiency of the cardiac differentiation of mouse embryonic stem cells. Tissue Cell. 2013 Feb;45(1):54-60. doi: 10.1016/j.tice.2012.09.005. 

​19. Rosca AM, Matei C, Dragan E et al. Cardiomyocyte apoptosis in ischaemia-reperfusion due to the exogenous oxidants at the time of reperfusion. Cell Biol Int. 2012;36(12):1207-15. doi: 10.1042/CBI20120080.

​20. Vasile E, Popescu LM, Piticescu RM et al. Physico-chemical and biocompatible properties of hydroxyapatite based composites prepared by an innovative synthesis route. Materials Letters. 2012, 79, pp. 85–88. doi.org/10.1016/j.matlet.2012.03.099.

​21. Rosca AM and Burlacu A. Effect of 5-azacytidine: evidence for alteration of the multipotent ability of mesenchymal stem cells. Stem Cells Dev. 2011 Jul;20(7):1213-21. doi: 10.1089/scd.2010.0433.

1. Preda MB and Burlacu A. Electrocardiography as a tool for validating myocardial ischemia-reperfusion procedures in mice. Comp Med. 2010 Dec;60(6):443-7. PMID: 21262130

​2. Rosca AM and Burlacu A. Isolation of a mouse bone marrow population enriched in stem and progenitor cells by centrifugation on a Percoll gradient. Biotechnol Appl Biochem. 2010 Apr 12;55(4):199-208. doi: 10.1042/BA20090356.

​3. Preda BM and Burlacu A. Animal models for in vivo ischemia studies. Annals of the Romanian Society for Cell Biology. 2010, 15(2), pp. 115–122. 

4. Rosca AM and Burlacu A. Characterization of mesenchymal stem cells isolated from mouse bone marrow. Annals of the Romanian Society for Cell Biology. 2010, 15(2), pp. 57–64. 

​5. Burlacu A, Rosca AM, Maniu H et al. Promoting effect of 5-azacytidine on the myogenic differentiation of bone marrow stromal cells. Eur J Cell Biol. 2008 Mar;87(3):173-84. doi: 10.1016/j.ejcb.2007.09.003. 

​6. Burlacu A. Can 5-azacytidine convert the adult stem cells into cardiomyocytes? A brief overview. Arch Physiol Biochem. 2006 Oct-Dec;112(4-5):260-4. doi: 10.1080/13813450601094631.

​7. Burlacu A. Regulation of apoptosis by Bcl-2 family proteins. J Cell Mol Med. 2003 Jul-Sep;7(3):249-57. doi: 10.1111/j.1582-4934.2003.tb00225.x.

​8. Gafencu A, Heltianu C, Burlacu A et al. Investigation of IgG receptors expressed on the surface of human placental endothelial cells. Placenta. 2003, 24(6), pp. 664–676. doi.org/10.1016/S0143-4004(03)00041-9.

​9. Burlacu A, Jinga V, Gafencu A et al. Severity of oxidative stress generates different mechanisms of endothelial cell death. Cell and Tissue Research. 2001, 306(3), pp. 409–416. doi.org/10.1007/s004410100424